1.00
price down icon1.96%   -0.02
after-market Dopo l'orario di chiusura: 1.01 0.01 +1.00%
loading

Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie

pulisher
May 06, 2026

What's going on with MIRA Pharma stock Tuesday? - MSN

May 06, 2026
pulisher
Apr 23, 2026

MIRA Pharmaceuticals (MIRA) Top Loser | Q3 2025: Profit SurprisesPost Earnings - UBND thành phố Hải Phòng

Apr 23, 2026
pulisher
Apr 22, 2026

Should I buy MIRA Pharmaceuticals (MIRA) stock right now | Q3 2025: EPS Exceeds ExpectationsMargin of Safety - UBND thành phố Hải Phòng

Apr 22, 2026
pulisher
Apr 16, 2026

MIRA Pharmaceuticals (MIRA) Stock: Momentum Analysis (Momentum Building) 2026-04-16Low Volatility Stocks - Xã Vĩnh Công

Apr 16, 2026
pulisher
Apr 14, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Apr 14, 2026
pulisher
Apr 13, 2026

MIRA Stock Price, Quote & Chart | MIRA PHARMACEUTICALS INC (NASDAQ:MIRA) - ChartMill

Apr 13, 2026
pulisher
Apr 09, 2026

Aug Summary: How does MIRA Pharmaceuticals Inc compare to its peersWeekly Investment Recap & AI Driven Stock Movement Reports - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 07, 2026

Is MIRA Pharmaceuticals (MIRA) Stock Good for Active Traders | Price at $1.03, Down 4.63%Bearish Pattern - Newser

Apr 07, 2026
pulisher
Apr 07, 2026

MIRA Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings | K6S | US60458C1045 - marketscreener.com

Apr 07, 2026
pulisher
Apr 06, 2026

MIRA Pharmaceuticals : Investor Presentation - marketscreener.com

Apr 06, 2026
pulisher
Apr 04, 2026

MIRA Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

MIRA completes Phase 1 trial of oral NMDA drug Ketamir-2 - Investing.com

Apr 03, 2026
pulisher
Apr 03, 2026

MIRA Stock Analysis: MIRA Pharmaceuticals Inc. rises 4.72 pct to hold 1.11 level - Newser

Apr 03, 2026
pulisher
Apr 02, 2026

MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026
pulisher
Apr 02, 2026

Investment Report: How does MIRA Pharmaceuticals Inc compare to its peersPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 02, 2026

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - 富途牛牛

Apr 02, 2026
pulisher
Apr 02, 2026

Mira Pharmaceuticals Inc (K6S.MU) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026
pulisher
Apr 01, 2026

MIRA Pharmaceuticals (MIRA) CEO granted 83,500 RSUs - Stock Titan

Apr 01, 2026
pulisher
Mar 31, 2026

MIRA Should I Buy - Intellectia AI

Mar 31, 2026
pulisher
Mar 31, 2026

Cash strain and trial progress at MIRA Pharmaceuticals (NASDAQ: MIRA) - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Mira Pharmaceuticals 10-K: $— Revenue, $(1.35) EPS, $(10.44)M Net Loss - tradingview.com

Mar 31, 2026
pulisher
Mar 31, 2026

MIRA Pharmaceuticals | 10-K: FY2025 Annual Report - Moomoo

Mar 31, 2026
pulisher
Mar 31, 2026

MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 31, 2026
pulisher
Mar 30, 2026

MIRA Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 30, 2026
pulisher
Mar 27, 2026

Institution Moves: Can MIRA Pharmaceuticals Inc deliver alphaWeekly Gains Summary & Daily Volume Surge Trade Alerts - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 26, 2026

Analyst Downgrade: What are MIRA Pharmaceuticals Incs recent SEC filings showing2026 WrapUp & Community Shared Stock Ideas - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Retail Surge: Is MIRA Pharmaceuticals Inc a strong growth stockMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

MIRA Pharmaceuticals, Inc.Common Stock (NQ:MIRA) - FinancialContent

Mar 25, 2026
pulisher
Mar 24, 2026

What's Going On With MIRA Pharma Stock Tuesday? - Benzinga

Mar 24, 2026
pulisher
Mar 24, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 24, 2026
pulisher
Mar 24, 2026

MIRA’s Mira-55 shows no CNS side effects in preclinical tests By Investing.com - Investing.com India

Mar 24, 2026
pulisher
Mar 23, 2026

MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55 - TipRanks

Mar 23, 2026
pulisher
Mar 23, 2026

MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies - The Desert Sun

Mar 23, 2026
pulisher
Mar 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 23, 2026
pulisher
Mar 23, 2026

Mira Pharmaceuticals, Inc. Announces Positive Preclinical Results for Mira-55, a Non-Opioid Pain and Anxiety Treatment - Minichart

Mar 23, 2026
pulisher
Mar 23, 2026

Mira Pharmaceuticals reports preclinical results for Mira-55 with no observed THC- or rimonabant-like CNS side effects - Investing.com India

Mar 23, 2026
pulisher
Mar 23, 2026

MIRA’s Mira-55 shows no CNS side effects in preclinical tests - investing.com

Mar 23, 2026
pulisher
Mar 23, 2026

MIRA pain drug showed morphine-like relief without THC-like effects - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

MIRA Pharmaceuticals (MIRA) posts Mira-55 CNS and pain preclinical data - Stock Titan

Mar 23, 2026
pulisher
Mar 22, 2026

Aug EndMonth: What is the Moat Score of MIRA Pharmaceuticals Inc2026 Macro Moves & Weekly Return Optimization Plans - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 20, 2026

Momentum Shift: Can MIRA Pharmaceuticals Inc maintain its current growth rateRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 20, 2026

Macro Review: Can MIRA Pharmaceuticals Inc maintain its current growth rateTrade Ideas & Reliable Price Breakout Signals - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 18, 2026

Dividend Watch: Can MIRA Pharmaceuticals Inc deliver alphaQuarterly Profit Report & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 18, 2026
PFE PFE
$26.53
price up icon 0.30%
$136.30
price up icon 2.11%
$331.11
price up icon 0.46%
NVO NVO
$45.76
price up icon 1.98%
MRK MRK
$113.56
price up icon 0.36%
NVS NVS
$148.36
price up icon 1.97%
Capitalizzazione:     |  Volume (24 ore):